Additional information
Laboratory | Exult Diagnostics, Dr. Lal PathLabs |
---|
Laboratory | Exult Diagnostics, Dr. Lal PathLabs |
---|
₹ 1600
EX0054 ALDOSTERONE, PLASMA | |||||||
Specimen: | 3 mL (2.5 mL min.) plasma from 1 Lavender Top (EDTA) tube. | ||||||
Stability: |
|
||||||
Method: | CLIA | ||||||
Comment: | A complete investigation of Aldosterone pathophysiology must include assessment of PLASMA RENIN DIRECT. | ||||||
Report: | Contact us to know the TAT. | ||||||
Usage: | This assay is useful in the investigation of Primary Aldosteronism (Adrenal Adenoma / Carcinoma and Adrenal Cortical Hyperplasia) and Secondary Aldosteronism (Renovascular disease, salt depletion, potassium loading, cardiac failure with ascites, and pregnancy). | ||||||
Doctor Specialty: | Endocrinologist | ||||||
Disease: | Disorders of Adrenal Gland | ||||||
Components: | |||||||
Courier Charges: | 0.00 | ||||||
Home Collection: | Available (*T&C Apply) | ||||||
Department: | Biochemistry | ||||||
Pre Test Information: | The patient should be ambulatory/upright 2 hours prior to sampling. Drug interactions to be noted: Potassium wasting diuretics, Spironolactone, Eplerenone, Amiloride, and Triamterene should be discontinued at least for 4 weeks; Adrenergic blockers, Clonidine, Methyldopa, NSAIDs, Angiotensin-converting enzyme inhibitors, Angiotensin receptor blockers, Renin inhibitors, and Dihydropyridine calcium channel antagonists should be discontinued for 2 weeks. If necessary to maintain hypertension control, patients should be treated with other antihypertensive medications like Verapamil slow-release, Hydralazine, Prazosin, Doxazosin & Terazosin that have lesser effects on Plasma renin & aldosterone levels. Any change in medication should be done in consultation with the treating physician. |
a division of exult cares pvt. ltd.
Reviews
There are no reviews yet.